Healthcare (Substance Abuse)

S 2893 requires landlords to obtain written approval from New Jersey's Department of Health (DOH) before evicting or interfering with hospital operators or their successors. This applies to any "adverse possessory action," such as lease termination or removal from hospital property, directly affecting hospital operators, landlords, and the DOH. The bill mandates DOH approval for such actions based on "just cause," with violations resulting in civil penalties up to $1 million, license suspensions, and potential criminal charges for actions causing hospital closures. It also ensures hospitals can seek financial recovery for revenue losses due to unauthorized actions.

SJR 31 establishes the New Jersey Pharmacogenomics Commission to study how a person's genetic makeup affects medication effectiveness and safety (pharmacogenomics). The 13-member commission, appointed by the Governor and legislative leaders, will examine costs, benefits for patients and providers, applications like opioid crisis response, and potential reductions in adverse drug events. It must hold public hearings in northern and southern New Jersey within six months of forming and submit a final report to the Governor and Legislature within six months of its organization. The commission expires after submitting this report, which will inform potential future policy decisions. This is a study commission only - no new laws or funding are created by the bill.